Lixte Biotechnology Holdings, Inc.

NASDAQ:LIXT

Biotechnology

Healthcare
$7.21 +6.61%

+$0.46 today

Market cap
$89.11M
Beta
1.05
P/E (TTM)
-11.1
EPS (TTM)
-$0.67
52W Low $0.68High $7.78

Volume 0.61M

Average 0.12M

LIXT Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Lixte Biotechnology Holdings, Inc.NASDAQ: LIXT

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin not reported for Q1 FY2026

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
—— QoQ
Last fiscal yearDec 2025
—— YoY
LTMMar 2026
—— YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How LIXT compares with its peers on the latest reported figures

No competitor Gross Margin figures are available to compare.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development1.74M1.35M898.1K726.23K254.92K
Selling, General & Admin4.98M4.96M4.19M2.85M4.85M
Operating Expenses6.72M6.31M5.09M3.57M5.11M
Depreciation & Amortization00000
EBITDA(6.72M)(6.3M)(5.07M)(3.57M)(6M)
EBITDA Margin—————
Operating Income(6.72M)(6.31M)(5.09M)(3.57M)(5.11M)
Operating Margin—————
Interest Income62611.2K17.49K7.05K7.39K
Interest Expense7.41K8.88K16.23K16.82K9.16K
Other Income / Expenses(7.95K)(1.05K)3.21K(13.18K)(901.9K)
Income Before Tax(6.73M)(6.31M)(5.09M)(3.59M)(6.01M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(6.73M)(6.31M)(5.09M)(3.59M)(6.01M)
Net Margin—————
EPS (Basic)(5.00)(4.00)(2.66)(1.59)(1.26)
EPS (Diluted)(5.00)(4.00)(2.66)(1.59)(1.26)
Weighted Avg Shares1.35M1.58M1.91M2.25M48.41M
Weighted Avg Shares (Diluted)1.35M1.58M1.92M2.25M48.41M

Lixte Biotechnology Holdings, Inc.

NASDAQ:LIXT

Intrinsic Alpha fair value

Locked

Current Price

$7.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.